ROBO-NEWS

Delivering Cutting Edge Industry Insight And Competitive Intelligence

Medical Robotics Market Continues to Soar for Investors, But Patients Are the Biggest Winners

Written by: Bill Studebaker, CIO at ROBO Global

On Tuesday, Orian Research released a report on the current state of the healthcare robotics market growth. Their estimates may surprise even those who are focused on this sector. In brief, the growth to come is expected to be nothing short of explosive: the current market of $4.12 billion is expected to reach $13.9 billion by 2023. That’s a compound annual growth rate of 27.53% over the next six years.[1] It’s stunning.

What may be even more surprising is that, historically, analysts have far underestimated the true growth potential for the medical robotics market. Just look at Intuitive Surgical. Back in 2003, analysts called the company’s stock overvalued and warned investors that buying shares at a price tag of just over $5 was a risky proposition. Today, Intuitive Surgical is hovering at around $370 per share. More so, some analysts are predicting that the company is still in its infancy even today. In response to recent earnings releases, analysts at Goldman Sachs and Wells Fargo upgraded their targets for the stock to an almost shocking $1,000.[2]

Intuitive Surgical has a virtual monopoly on surgical robotics with its da Vinci Xi®system which uses 3D vision and intuitive motion to support minimally invasive procedures and help surgeons deliver better outcomes at a lower cost. In terms of the ROBO Global Robotics & Automation Index Classification System, Intuitive Surgical is considered a “pure-play” or bellwether company in the industry—a well-established leader whose core business is directly related to robotics and automation and that typically operates on a global scale. But Intuitive is certainly not alone in its efforts to push the boundaries of healthcare robotics, an area that has quickly become the new hotbed for the application of robotics, automation, and artificial intelligence (or “RAAI”) attracting investors to the theme.

Mazor Robotics was recently called out as having the “three things investors love”: robots, recurring revenue, and rapid growth. With a focus on spine and brain surgery, it too can be viewed as holding its own subsector monopoly, and investors are taking note. Following the company’s Q2 earnings report, the stock jumped 20% in July. IBM is also on the rise. Its Watson supercomputer is already transforming personalized treatment advice, and its latest $240 Million investment in its MIT–IBM Watson AI Lab was the source of an unexpected boost in revenues. After the Q3 earnings report announced revenue of $19.15 billion, leapfrogging previous outlooks of $18.6 billion, its stock price jumped up 10% to just below $160/share.

Related: Investing in Healthcare Robotics

This is one case when everyone is quite happy to see miscalculations by the analysts. Not only are investors in healthcare robotics more than pleased, but the innovations that are driving these spectacular revenues are reshaping the healthcare industry itself. Surgical robots can now perform complex surgeries with sub-millimeter accuracy, enabling older surgeons who may be at the top of their game intellectually but not physically to achieve better patient outcomes. Artificial intelligence is being used to view and expertly analyze medical images that containing millions of cancer cells—within minutes and at a level of accuracy not possible by humans. Automation is creating enormous efficiencies across the healthcare system to improve and accelerate workflows. RAAI technologies are enabling earlier, more accurate diagnoses; reducing the invasiveness of a multitude of surgeries—brain, spine, heart, vein, and more; delivering unmatched insights to radiology and pathology processes; and significantly reducing the cost and negative implications of misdiagnosis.

Investors are certainly happy with this level of innovation and growth, but patients are clearly the biggest winners.


Innovations in healthcare robotics are making it possible to identify, invent, investigate, and implement technologies that deliver the right treatment to the right patient at that right time—and at the right cost. The wheels are already in motion to use robotics to enable the holy grail of taking patients from symptom to diagnosis to treatment in a single day. Wearable robotics are being used to detect and prevent a variety of health problems, from breast cancer to cardiac arrest. Just like the Star Trek tricorder, handheld, intelligent computers are being used to sense, compute and record a patient’s health status. The device has been called “a complete office visit in a 5-pound box.”

It’s no wonder analysts have rather consistently failed to predict this momentum of growth. Innovation is happening at such a fast and furious pace that it is becoming difficult to even imagine what’s coming next in healthcare robotics. Today, a surgical robot can slice a tiny grape into four perfect quadrants, peel the grape to remove precisely 1/100th of a centimeter of skin, and leave the rest of the grape perfectly in tact. That level of sub-millimeter accuracy was unthinkable just a decade ago. If the rate of innovation continues at such lightning speed (and there’s no reason to expect anything less), healthcare as we know it will be relegated to the history books.

Any way you slice it (pun intended), the growth across the sector has been spectacular. Within the ROBO Global Robotics & Automation Index, the healthcare robotics subsector alone has grown 127% in the past 4 years. That growth continues to be fuelled by new advancements in technology, increases in research and development spending, and an exponential rise in demand for minimally invasive surgical procedures. With no end to this innovation or the demand for it in sight, robotics in healthcare may very well be the fuel many investors are seeking today to help drive up portfolio returns for years to come.

[1] Source: Global Market for Robotics In Healthcare On The Basis Of Technology, Type Of System (Surgical, Assistive, Rehabilitative), Application And Region 2017—Forecasts till 2023. Orian Research. November 2017

[2] Source: “What Will It Take For Intuitive Surgical To Be A $1000 Stock?,” Forbes, May 31, 2017

You are now leaving the ROBO Global website. The following landing page may contain information concerning investments, products or other information. Exchange Traded Concepts LLC, the Fund Advisor are not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by the entities that are not affiliated with Exchange Traded Concepts LLC. Descriptions of, references to, or links to products or publications within any non-affiliated linked website does not imply endorsement of that product or publication by Exchange Traded Concepts LLC. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of Exchange Traded Concepts LLC, which is not responsible for any inaccuracies or errors.

Proceed

You are now leaving the ROBO Global Partners Ltd website and being directed to ETF Securities (UK) Limited which is authorized and regulated by the United Kingdom Financial Conduct Authority (the “FCA”). By clicking “OK”, you acknowledge that you are someone authorized to undertake investment activities relating to the Exchange Traded Funds (ETFs). IN addition, you understand that ROBO Global Partners Ltd is not making any financial promotion or carrying out any regulated activity of said products. The following landing page may contain information concerning investments, products or other information. ETF Securities (UK) Limited is not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by entities that are not affiliated with ETF Securities (UK) Limited. Descriptions of references to, or links to products or publications within any non-affiliated linked websites does not imply endorsement of that product or publication by ETF Securities (UK) Limited. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of ETF Securities (UK) Limited, which is not responsible for any inaccuracies or errors.

Proceed

ROBO Global Privacy Policy

This privacy policy has been compiled to better serve those who are concerned with how their 'Personally identifiable information' (PII) is being used online. PII, as used in US privacy law and information security, is information that can be used on its own or with other information to identify, contact, or locate a single person, or to identify an individual in context. Please read our privacy policy carefully to get a clear understanding of how we collect, use, protect or otherwise handle your Personally Identifiable Information in accordance with our website.
What personal information do we collect from the people that visit our blog, website or app?
When subscribing or registering on our site, as appropriate, you may be asked to enter your name or email address.
When do we collect information?
We collect information from you when you register on our site, subscribe to a newsletter, fill out a form or enter information on our site.
How do we use your information?
We may use the information we collect from you when you register, sign up for our newsletter, respond to a survey or marketing communication or use certain other site features in the following ways:
  • To administer a contest, promotion, survey or other site feature.
  • To send periodic emails regarding our firm.
How do we protect visitor information?
We do not use vulnerability scanning and/or scanning to PCI standards.
We do not use Malware Scanning.
We do not use an SSL certificate
  • We do not need an SSL because:
We don't keep information on website
Do we use 'cookies'?
You can choose to have your computer warn you each time a cookie is being sent, or you can choose to turn off all cookies. You do this through your browser (like Internet Explorer) settings. Each browser is a little different, so look at your browser's Help menu to learn the correct way to modify your cookies.
If you disable cookies off, some features will be disabled that make your site experience more efficient and some of our services will not function properly.
Third Party Disclosure
We do not sell, trade, or otherwise transfer to outside parties your personally identifiable information.
Third party links
We do not include or offer third party products or services on our website.
We have implemented the following:
  • Google Display Network Impression Reporting
  • Demographics and Interests Reporting
We along with third-party vendors, such as Google use first-party cookies (such as the Google Analytics cookies) and third-party cookies (such as the DoubleClick cookie) or other third-party identifiers together to compile data regarding user interactions with ad impressions, and other ad service functions as they relate to our website.
Opting out:
Users can set preferences for how Google advertises to you using the Google Ad Settings page. Alternatively, you can opt out by visiting the Network Advertising initiative opt out page or permanently using the Google Analytics Opt Out Browser add on.
California Online Privacy Protection Act
CalOPPA is the first state law in the nation to require commercial websites and online services to post a privacy policy. The law's reach stretches well beyond California to require a person or company in the United States (and conceivably the world) that operates websites collecting personally identifiable information from California consumers to post a conspicuous privacy policy on its website stating exactly the information being collected and those individuals with whom it is being shared, and to comply with this policy. - See more at: http://consumercal.org/california-online-privacy-protection-act-caloppa/#sthash.0FdRbT51.dpuf
According to CalOPPA we agree to the following:
Users can visit our site anonymously
Once this privacy policy is created, we will add a link to it on our home page, or as a minimum on the first significant page after entering our website.
Our Privacy Policy link includes the word 'Privacy', and can be easily be found on the page specified above.
Users will be notified of any privacy policy changes:
  • On our Privacy Policy Page
Users are able to change their personal information:
  • By emailing us
How does our site handle do not track signals?
We honor do not track signals and do not track, plant cookies, or use advertising when a Do Not Track (DNT) browser mechanism is in place.
Does our site allow third party behavioral tracking?
It's also important to note that we do not allow third party behavioral tracking
COPPA (Children Online Privacy Protection Act)
When it comes to the collection of personal information from children under 13, the Children's Online Privacy Protection Act (COPPA) puts parents in control. The Federal Trade Commission, the nation's consumer protection agency, enforces the COPPA Rule, which spells out what operators of websites and online services must do to protect children's privacy and safety online.
We do not specifically market to children under 13.
Fair Information Practices
The Fair Information Practices Principles form the backbone of privacy law in the United States and the concepts they include have played a significant role in the development of data protection laws around the globe. Understanding the Fair Information Practice Principles and how they should be implemented is critical to comply with the various privacy laws that protect personal information.
In order to be in line with Fair Information Practices we will take the following responsive action, should a data breach occur:
  • Within 7 business days
We will notify the users via in site notification
  • Within 7 business days
We also agree to the individual redress principle, which requires that individuals have a right to pursue legally enforceable rights against data collectors and processors who fail to adhere to the law. This principle requires not only that individuals have enforceable rights against data users, but also that individuals have recourse to courts or a government agency to investigate and/or prosecute non-compliance by data processors.
CAN SPAM Act
The CAN-SPAM Act is a law that sets the rules for commercial email, establishes requirements for commercial messages, gives recipients the right to have emails stopped from being sent to them, and spells out tough penalties for violations.
To be in accordance with CANSPAM we agree to the following:
If at any time you would like to unsubscribe from receiving future emails, you can email us at info@robostox.com
and we will promptly remove you from ALL correspondence.
Contacting Us
If there are any questions regarding this privacy policy you may contact us using the information below.
www.roboglobal.com
300 Crescent Court, Suite 840
Dallas, TX 75201
US
info@roboglobal.com
214 272 2710